Citation Impact
Citing Papers
Heparin-Protein Interactions
2002 Standout
Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage
2008
Nonlinear magic: multiphoton microscopy in the biosciences
2003 Standout
Memantine in Moderate-to-Severe Alzheimer's Disease
2003 Standout
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
2007 Standout
Advances in the development of biomarkers for Alzheimer’s disease: from CSF total tau and Aβ1–42 proteins to phosphorylated tau protein
2003
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Cerebrospinal fluid protein biomarkers for Alzheimer’s disease
2004
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
2005 Standout
CSF markers for incipient Alzheimer's disease
2003
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
2009 Standout
Decreased β-Amyloid1-42and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease
2003
Longitudinal stability of CSF tau levels in Alzheimer patients
1999
Neurobiological Mechanisms of the Placebo Effect
2005
Neuroplasticity Failure in Alzheimer's Disease
1999
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study
1998
Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease
1999
CSF Biomarkers for Alzheimer’s Disease: Levels of β-Amyloid, Tau, Phosphorylated Tau Relate to Clinical Symptoms and Survival
2006
Pathogenic theories and intrathecal analysis of the sporadic form of Alzheimer’s disease
2002
Sexual dimorphism in predisposition to Alzheimer's disease
2018
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Diagnosis of Alzheimer's Disease
1997
Combination of the different biological markers for increasing specificity of in vivo Alzheimer’s testing
1998
Parkinson's disease
2015 Standout
Cerebrospinal Fluid Tau Levels in Neurodegenerative Diseases with Distinct Tau-Related Pathology
1997
Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy
2001
Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease
2003 Standout
Alzheimer's disease
2006 Standout
Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles
2003 Standout
Apolipoprotein E and atherosclerosis: insight from animal and human studies
1999
Normal and Pathological Tau Proteins as Factors for Microtubule Assembly
1997
Current Concepts in Mild Cognitive Impairment
2001 Standout
tau protein in cerebrospinal fluid
1995
Alzheimer's Disease
2010 Standout
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
2003 Standout
A sandwich enzyme immunoassay for measuring AD7C-NTP as an Alzheimer's disease marker: AD7C test
1998
Longitudinal Assessment of Neurocognitive Function after Coronary-Artery Bypass Surgery
2001 Standout
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work.
2000 Standout
Tau protein and the neurofibrillary pathology of Alzheimer's disease
1993
Abnormally phosphorylated tau protein in Alzheimer's disease: Heterogeneity of individual regional distribution and relationship to clinical severity
1994
Detection of Proteins in Normal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme‐Linked Immunosorbent Assay
1993
AGING, MILD COGNITIVE IMPAIRMENT, AND ALZHEIMER'S DISEASE
2000
Alzheimer's Disease
2004 Standout
Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment
1999
Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
2003 Standout
Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension
1995
Non-specific low back pain
2011 Standout
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
2003 Standout
Biological, clinical, and ethical advances of placebo effects
2010
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Mild cognitive impairment as a diagnostic entity
2004 Standout
High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E Genotype
1998
Cerebrospinal protein tau is elevated in early Alzheimer's disease
1996
Single-cell transcriptomic analysis of Alzheimer’s disease
2019 StandoutNature
Biological fluid biomarkers in neurodegenerative parkinsonism
2009
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Delirium in Mechanically Ventilated Patients
2001 Standout
The molecular pathology of Alzheimer's disease
1991 Standout
Cancer of the Ovary
2004 Standout
β/A4‐evoked degeneration of differentiated SH‐SY5Y human neuroblastoma cells
1994
The amyloid hypothesis of Alzheimer's disease at 25 years
2016 Standout
Biosensing with plasmonic nanosensors
2008 Standout
Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample
1999
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
2005 Standout
Arterial Stiffness and Cardiovascular Events
2010 Standout
Granulosa Cell Tumor of the Ovary
2003
Midlife vascular risk factors and late-life mild cognitive impairment
2001
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery
2008 Standout
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
1998 Standout
AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease
1996
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Practice parameter: Diagnosis of dementia (an evidence-based review)
2001
Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSF
1999
Alzheimer's Disease: Genes, Proteins, and Therapy
2001 Standout
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Developmental expression of tau proteins in the chicken and rat brain: Rapid down‐regulation of a paired helical filament epitope in the rat cerebral cortex coincides with the transition from immature to adult tau isoforms
1995
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Microtubular Proteolysis in Focal Cerebral Ischemia
1996
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
2011 Standout
Physical Activity and Public Health in Older Adults
2007 Standout
Ischemic Cell Death in Brain Neurons
1999 Standout
Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease
1995
A Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought
2007 Standout
Vascular Risk Factors: Imaging and Neuropathologic Correlates
2010
Objective changes in motor function during placebo treatment in PD
2000
Nanostructures in Biodiagnostics
2005 Standout
Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease
2005
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
1996 StandoutNature
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Mild Cognitive Impairment
2016
The Neurofibrillary Pathology of Alzheimer's Disease
1997
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
2005 Standout
Works of Barney E. Miller being referenced
A sandwich enzyme immunoassay for detecting and measuring alzheimer's disease‐associated proteins in human brain tissue
1990
Peak B endorphin concentration in cerebrospinal fluid: reduced in chronic pain patients and increased during the placebo response
1990
Detection of amyloid beta protein precursor immunoreactivity in normal and Alzheimer's disease cerebrospinal fluid
1990
Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease
1997
Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease
1995
Phosphorylated Tau Epitope of Alzheimer's Disease Is Coupled to Axon Development in the Avian Central Nervous System
1993
Automated microparticle enzyme immunoassay for neural thread protein in cerebrospinal fluid from alzheimer's disease patients
1992
Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins
1998
Parameters of differentiation and proliferation in adult granulosa cell tumors of the ovary.
2001